Home/Filings/4/0001104659-21-020197
4//SEC Filing

Beebe Katherine 4

Accession 0001104659-21-020197

CIK 0000910267other

Filed

Feb 10, 7:00 PM ET

Accepted

Feb 11, 6:37 AM ET

Size

5.3 KB

Accession

0001104659-21-020197

Insider Transaction Report

Form 4
Period: 2021-02-10
Beebe Katherine
Chief Scientific Officer
Transactions
  • Award

    Option to Purchase Common Stock

    2021-02-10+150,000150,000 total
    Exercise: $4.02Exp: 2031-02-10Common Stock (150,000 underlying)
Footnotes (1)
  • [F1]The options vest as to 75,000 shares on August 10, 2021 with the balance to vest in equal monthly installments over the 18 months thereafter.

Issuer

TITAN PHARMACEUTICALS INC

CIK 0000910267

Entity typeother

Related Parties

1
  • filerCIK 0001768867

Filing Metadata

Form type
4
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 6:37 AM ET
Size
5.3 KB